What are Live attenuated combination vaccine drugs?

Live attenuated combination vaccine drugs are pharmacologic agents that share a common mechanism. 1 are currently marketed, with 3 more in clinical development.

What are the marketed Live attenuated combination vaccine drugs?

Marketed Live attenuated combination vaccine drugs include ProQuad®.

Live attenuated combination vaccine

1 marketed 3 in Phase 3

This page covers all Live attenuated combination vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (1)

ProQuad® · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
ProQuad is a live attenuated combination vaccine that stimulates immune response against measles, mumps, rubella, and varicella viruses.

Phase 3 pipeline (3)

Comparator: ProQuad™ (V221) · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
ProQuad is a live attenuated combination vaccine that stimulates immune response against measles, mumps, rubella, and varicella viruses.
MMRV (2006 process) · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
MMRV is a live attenuated combination vaccine that provides immunization against measles, mumps, rubella, and varicella by stimulating immune responses to all four viruses.
MMRV (AMP) · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
MMRV is a live attenuated combination vaccine that provides immunization against measles, mumps, rubella, and varicella by stimulating adaptive immune responses to all four viruses.